Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annu...(ur primaryfocus is the commercialization...),Health

Date:5/12/2008

ur primary focus is the commercialization of our Urgent PC system, which we believe is the only FDA-approved non-surgical neurostimulation therapy for the treatment of urinary symptoms often associated with overactive bladder (OAB). We also offer Macroplastique(R) Implants, a urethral bulking agent for the treatment of adult female stress urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.

For Further Information:

Uroplasty, Inc. EVC Group

David Kaysen, President and CEO, or Doug Sherk/Matt Selinger (Investors)

Medi Jiwani, Vice President, CFO, 415.896.6820

and Treasurer, Steve DiMattia/Chris Gale (Media)

952.426.6140 646.201.5445

'/>"/>

SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Uroplasty Plans to Double Sales Force During Fiscal 2009
2. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
3. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
4. Uroplasty Expands Marketing Program for Urology Practices
5. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
6. Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter
7. Uroplasty to Host Second Quarter Conference Call on November 1
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. Highlights for APAs 116th Annual Convention in Boston, Aug. 14-17
10. Isis Reports Financial Results and Highlights for First Quarter of 2008
11. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease